Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Nutritional Supplement ONCOXIN in Patients With Breast Fibrocystic Disease

NCT00967681 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT00967681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Nutritional Supplement ONCOXIN in Patients With Breast Fibrocystic Disease
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
April 30, 2011
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast fibrocystic disease